BIOCON.NSE logo

BIOCON.NSE
Biocon

733
Loading...
Loading...
News
all
press releases
US tariff on pharma unlikely to hit Indian drugmakers: Biocon CEO
… at branded and patented drugs , with generics and biosimilars … essential sector. "While pharmaceuticals are relatively resilient, any prolonged … cautiously optimistic. Demand fundamentals for pharmaceuticals --especially generics, biosimilars, and …
cityfalcon.com·1d ago
News Placeholder
More News
News Placeholder
Trump’s 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Biocon CEO
The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to cause immediate disruption to Indian drugmakers, as the move largely targets branded medicines while exempting generics and biosimilars, said Siddharth Mittal, CEO and Managing Director of Biocon Limited.
cityfalcon.com·2d ago
News Placeholder
Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas Tambe
Biocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management drug. Biocon aims to become a global medicines company driven by innovation. Insulin remains a strategic anchor. Oncology and immunology are key pillars. New areas like ophthalmology are being explored. Investments will target technology and AI.
cityfalcon.com·8d ago
News Placeholder
Biocon installs first CEO as integration sharpens global ambitions
Indian biopharma Biocon has appointed Shreehas Tambe as chief executive and managing director, marking the first time a single executive will lead its combined biosimilars and generics business.
cityfalcon.com·8d ago
News Placeholder
St Patrick’s Day celebrated in Bengaluru with focus on India-Ireland ties
Bengaluru: Kiran Mazumdar-Shaw, honorary Consul General of Ireland and chairperson of Biocon, and Kevin Kelly, Ambassador of Ireland to India, hosted .
cityfalcon.com·13d ago
<
...
1
>

Latest BIOCON.NSE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.